862875
Last Update Posted: 2014-05-07
Recruiting has ended
All Genders accepted | 18 Years-80 Years |
42 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Levemir-Body Composition and Energy Metabolism
The objectives is to compare the changes in body composition (primary objective), diabetes parameters, energy expenditure and energy intake between Insulin detemir (Levemir® - Novolin® 4 pen) and insulin glargine (Lantus® - Solostar®) both in combination with Metformin and insulin secretagogues (SU) between baseline and after 6 months of insulin therapy in 80 type 2 diabetic patients failing on oral diabetic agents .
Eligibility
Relevant conditions:
Type 2 Diabetes
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov